Image
  • About Us
  • Team
  • Portfolio
  • Philanthropy
  • Trending
  • Contact
  • Login

KAI Pharmaceuticals Initiates Phase 2b Clinical Study of KAI-9803 in Heart Attack Patients

admin December 17, 2008 Portfolio News

Learn More-External Link

Back

Topics

News Archives

Image
Privacy Policy Terms of Use©2022 Lumira Ventures
  • About Us
  • Team
  • Portfolio
  • Philanthropy
  • Trending
  • Contact
  • Login